snmjournals.org

Primary Staging of Intermediate- and High-Risk Prostate Cancer Using

Journal of Nuclear Medicine November 2025, jnumed.125.270710; DOI: https://doi.org/10.2967/jnumed.125.270710 ...
snmjournals.org

High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?

Journal of Nuclear Medicine December 2025, jnumed.125.271318; DOI: https://doi.org/10.2967/jnumed.125.271318 ...
snmjournals.org

Reply: The Role of HER2 PET in Treatment of Breast Cancer

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
snmjournals.org

Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors

Journal of Nuclear Medicine November 2025, jnumed.125.270568; DOI: https://doi.org/10.2967/jnumed.125.270568 ...
snmjournals.org

Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration

Journal of Nuclear Medicine December 2025, jnumed.125.270802; DOI: https://doi.org/10.2967/jnumed.125.270802 ...
snmjournals.org

Diagnostic Accuracy of Fully Hybrid PET/MRI with

Journal of Nuclear Medicine November 2025, jnumed.125.269782; DOI: https://doi.org/10.2967/jnumed.125.269782 ...
snmjournals.org

Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases

Lewy body diseases (LBDs) feature profound myocardial depletion of the sympathetic neurotransmitter norepinephrine. In addition to sympathetic neuronal loss, the norepinephrine deficiency may reflect ...
snmjournals.org

PSMA-Directed PET/MRI Enables Noninvasive Diagnosis and Prognosis in Patients with Increased PSA Levels: Results from the Prospective Randomized RAPID Trial

Journal of Nuclear Medicine November 2025, jnumed.125.270404; DOI: https://doi.org/10.2967/jnumed.125.270404 ...
snmjournals.org

Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise

The field of theranostics dates back over 80 y, when Hertz and Roberts first used radioactive iodine to treat thyroid disease. Recent theranostic approvals for neuroendocrine tumors and prostate ...
snmjournals.org

Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with

Journal of Nuclear Medicine November 2025, jnumed.125.270508; DOI: https://doi.org/10.2967/jnumed.125.270508 ...
snmjournals.org

Outcomes of Peptide Receptor Radionuclide Therapy with

Journal of Nuclear Medicine November 2025, jnumed.125.270481; DOI: https://doi.org/10.2967/jnumed.125.270481 ...